Literature DB >> 21470770

RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.

Naomi Walsh1, AnneMarie Larkin, Niall Swan, Kevin Conlon, Paul Dowling, Ray McDermott, Martin Clynes.   

Abstract

We previously identified Hop as over expressed in invasive pancreatic cancer cell lines and malignant tissues of pancreatic cancer patients, suggesting an important role for Hop in the biology of invasive pancreatic cancer. Hop is a co-chaperone protein that binds to both Hsp70/Hsp90. We hypothesised that by targeting Hop, signalling pathways modulating invasion and client protein stabilisation involving Hsp90-dependent complexes may be altered. In this study, we show that Hop knockdown by small interfering (si)RNA reduces the invasion of pancreatic cancer cells, resulting in decreased expression of the downstream target gene, matrix metalloproteinases-2 (MMP-2). Hop in conditioned media co-immunoprecipitates with MMP-2, implicating a possible extracellular function for Hop. Knockdown of Hop expression also reduced expression levels of Hsp90 client proteins, HER2, Bcr-Abl, c-MET and v-Src. Furthermore, Hop is strongly expressed in high grade PanINs compared to lower PanIN grades, displaying differential localisation in invasive ductal pancreatic cancer, indicating that the localisation of Hop is an important factor in pancreatic tumours. Our data suggests that the attenuation of Hop expression inactivates key signal transduction proteins which may decrease the invasiveness of pancreatic cancer cells possibly through the modulation of Hsp90 activity. Therefore, targeting Hop in pancreatic cancer may constitute a viable strategy for targeted cancer therapy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21470770     DOI: 10.1016/j.canlet.2011.03.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  44 in total

Review 1.  Hsp90 inhibitors and drug resistance in cancer: the potential benefits of combination therapies of Hsp90 inhibitors and other anti-cancer drugs.

Authors:  Xiangyi Lu; Li Xiao; Luan Wang; Douglas M Ruden
Journal:  Biochem Pharmacol       Date:  2011-11-22       Impact factor: 5.858

2.  Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival.

Authors:  M H Lopes; T G Santos; B R Rodrigues; N Queiroz-Hazarbassanov; I W Cunha; A P Wasilewska-Sampaio; B Costa-Silva; F A Marchi; L F Bleggi-Torres; P I Sanematsu; S H Suzuki; S M Oba-Shinjo; S K N Marie; E Toulmin; A F Hill; V R Martins
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

Review 3.  The human HSP70 family of chaperones: where do we stand?

Authors:  Jürgen Radons
Journal:  Cell Stress Chaperones       Date:  2016-02-10       Impact factor: 3.667

4.  HSP90 and HSP70 proteins are essential for stabilization and activation of WASF3 metastasis-promoting protein.

Authors:  Yong Teng; Lambert Ngoka; Yun Mei; Leslieann Lesoon; John K Cowell
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

5.  Trophoblast survival signaling during human placentation requires HSP70 activation of MMP2-mediated HBEGF shedding.

Authors:  Chandni V Jain; Philip Jessmon; Charbel T Barrak; Alan D Bolnick; Brian A Kilburn; Michael Hertz; D Randall Armant
Journal:  Cell Death Differ       Date:  2017-07-21       Impact factor: 15.828

6.  Increased expression of stress inducible protein 1 in glioma-associated microglia/macrophages.

Authors:  Anna Carolina Carvalho da Fonseca; Huaqing Wang; Haitao Fan; Xuebo Chen; Ian Zhang; Leying Zhang; Flavia Regina Souza Lima; Behnam Badie
Journal:  J Neuroimmunol       Date:  2014-06-27       Impact factor: 3.478

7.  HOP expression is regulated by p53 and RAS and characteristic of a cancer gene signature.

Authors:  Stacey A Mattison; Gregory L Blatch; Adrienne L Edkins
Journal:  Cell Stress Chaperones       Date:  2016-12-16       Impact factor: 3.667

8.  Expression of stress-induced phosphoprotein1 (STIP1) is associated with tumor progression and poor prognosis in epithelial ovarian cancer.

Authors:  Hanbyoul Cho; Sunghoon Kim; Ha-Yeon Shin; Eun Joo Chung; Haruhisa Kitano; Jae Hyon Park; Lucienne Park; Joon-Yong Chung; Stephen M Hewitt; Jae-Hoon Kim
Journal:  Genes Chromosomes Cancer       Date:  2014-02-01       Impact factor: 5.006

Review 9.  Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update.

Authors:  Daniel R Ciocca; Andre Patrick Arrigo; Stuart K Calderwood
Journal:  Arch Toxicol       Date:  2012-08-11       Impact factor: 5.153

10.  Prion protein binding to HOP modulates the migration and invasion of colorectal cancer cells.

Authors:  Tonielli Cristina Sousa de Lacerda; Bruno Costa-Silva; Fernanda Salgueiredo Giudice; Marcos Vinicios Salles Dias; Gabriela Pintar de Oliveira; Bianca Luise Teixeira; Tiago Goss Dos Santos; Vilma Regina Martins
Journal:  Clin Exp Metastasis       Date:  2016-04-25       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.